|1||Active, not recruiting||
Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer
OGX-427 in Castration Resistant Prostate Cancer Patients
A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.
Active, not recruiting
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
† Study has passed its completion date and status has not been verified in more than two years.